Recent literature highlighted the role of Multiple Human Papillomavirus (HPV) infections in the development of CIN2 + . A better understanding of single-genotype and combined multiple-genotype oncogenic potential has become essential to plan future screening and to evaluate the prospective susceptibility to high risk cervical lesions progression. Analysing the literature data, we evaluated the prevalence and the prognostic significance of multiple HPV infections and their type-specific interactions in women with ASCUS and L-SIL cytology. Multiple HPV infections are detected in about 16.7% of women with ASCUS cytology and in 28.7% of LSIL Pap smear results. In ASCUS patients the rates of severe biopsy proven lesions are 8.6% and 31.6% in women with single and multiple HPV infections respectively. Similarly, in women with LSIL cytology, the likelihood of CIN2 + is 12.5% in patients with single and 28.4% in those with multiple HPV infection. Despite the well-known oncogenic risk of HPV16 and HPV18, recent studies provide a new insight in the high prevalence of other HR-HPVs and their significant contribution to a large proportion of high-grade cervical lesions in women with ASCUS/LSIL. This review provides further evidence that multiple HR-HPV infection is a significant risk factor for severe cervical lesions in women with ASCUS and LSIL cytology, and highlights that increased oncogenic risk might be strictly associated with peculiar type-specific profiles.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.